Monday, October 05, 2026 | 12pm EDT: Accelerate Neurodegeneration Trials With Biomarker Strategies

X

Researchers Identify Multi-Action Drug Candidate For Type 2 Diabetes And Bone Disease

Posted on: in News | Life Science News | Pharma News
By:

Related Vitals

Sanofi Opens $925M Toronto Vaccine Facility
The investment expands Sanofi’s Toronto manufacturing footprint and will strengthen Canada’s domestic flu vaccine and pandemic-response capacity.
News

Northway Biotech Opens $70.8M Cell Therapy CDMO Facility in Vilnius, Lithuania
Vilnius, Lithuania, is home to Northway Biotech’s new cell therapy and personalized medicine manufacturing center.
News

From Oxfordshire to Wales: Where UK Life Sciences Investment Is Going in 2026
Cambridge is one of several UK life sciences hubs attracting new investment in R&D, manufacturing and biopharma infrastructure.
News

Bristol Myers Squibb Invests $2.3B in Houston Drug Manufacturing
Bristol Myers Squibb Houston manufacturing
News

Lilly and Resilience Invest $750M to Expand Medicine Production in Ohio
Lilly Resilience Ohio manufacturing investment
Pharmaville: Powering Life Sciences Location Strategy and FDI

Related Webinars

November 11, 2026

Potency Assays for Modern Biologics: Expert Insights and Future Trends
Hero - Desktop
November 16, 2026

Navigating the Evolving Landscape of Glomerular Disease Clinical Trials
Hero - Desktop
November 19, 2026

AI Governance in Clinical Trial Biometrics: A Practical Framework for Small-Mid Size Organizations
Hero - Desktop
November 17, 2026

Accelerate Upstream Process Development Using Hybrid Modeling
Hero - Desktop
November 17, 2026

Accelerate Biotech Patient Recruitment with Smarter Site Selection
Hero - Desktop